NPPA notified regarding the computation of retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 2mg

Aug 31, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on August 29, 2024, issued the notification regarding computation of retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 2mg.

The following stated namely: -

• The computation of Retail Price is based on data for January, 2024

• The Retail Price has been computed for Each vial Containing Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 2mg for M/s Synokem Pharmaceuticals Ltd (Manufacturer) & M/s Unison Pharmaceuticals Pvt Ltd.

• The Total MAT is 60,38,927

[Notification No. 19(4190)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT